SAINT
JOHN, NB and NEWTOWN,
Pa., June 28, 2022 /PRNewswire/
-- Elandas, Inc., a SaaS-based configurable technology
solutions provider, announced it has merged with long-standing
partner AccessSync, LLC, a US-based strategic market access
execution services provider. Together, Elandas and AccessSync
leadership combine decades of experience delivering integrated
market access planning and execution to accelerate growth in an
increasingly complex biopharma market access environment.
There is an emerging need to demystify the
market access execution pathway.
"This merger is a major step forward in ensuring our technology
allows key information to reach clients, health care professionals,
and patients, where it will have maximum impact on access and
outcomes," said Ryan Roberts, CEO.
"We are extremely excited to welcome the AccessSync team to
Elandas."
The new company's vision is to ensure that innovative biopharma
products reach appropriate patients through seamlessly connecting
people, data, and resources.
"The Elandas technology platform introduces unrivaled speed and
flexibility into this space, combining workflow and data automation
with the ability to tailor each individual user experience to
specific market access needs," said Tate
Rarick, Managing Director of AccessSync, Inc. "Coming
together represents a milestone in our shared quest to unlock the
full potential of our customers' market access strategies through
optimized planning and execution."
A seamless, integrated approach to market access is becoming
increasingly important. Specialty products now lead in new drug
approvals and often involve complex coverage, distribution, and
administration requirements. All these access elements interact,
and in combination can significantly impact competitive
positioning, office logistics, and patient affordability. There is
an emerging need to demystify the market access execution
pathway.
"The most exciting aspect of this merger is the ability to
integrate data, creative, and technology to drive informed
actions," said Rarick. "Working with our clients and their
partners, we can now fully leverage their organizational assets for
maximum effectiveness, enabling customized execution down to local
market and health care professional levels."
As a result of the acquisition, AccessSync, LLC will become
AccessSync, Inc., a wholly owned US subsidiary of Elandas, Inc.
About Elandas
Elandas specializes in creating tech-enabled, configurable
solutions for the market access activities of life sciences
businesses, supporting both specialty and retail brands. For more
information, please visit Elandas.com.
About AccessSync
AccessSync delivers strategic market access planning and
execution for biopharma companies seeking to accelerate growth in
increasingly complex market access environments. For more
information, please visit AccessSync.com.
Contact:
Karen Schaffer
610-633-1404
media@AccessSync.com
View original
content:https://www.prnewswire.com/news-releases/elandas-and-accesssync-merger-delivers-seamless-solutions-for-market-access-execution-301575988.html
SOURCE AccessSync